Expert Opinion on Therapeutic Targets,
Год журнала:
2022,
Номер
26(3), С. 233 - 259
Опубликована: Март 4, 2022
Introduction
The
analysis
of
the
role
mitochondria
in
oxidative
damage
and
skin
aging
has
been
a
significant
aspect
dermatological
research.
Mitochondria
generate
most
reactive
oxygen
species
(ROS)
which,
excess,
are
cytotoxic
DNA-damaging
promote
(photo-)aging.
However,
ROS
also
possesses
key
physiological
regulatory
functions
mitochondrial
dysfunction
is
prominent
several
not
primarily
senescence-associated
diseases
cancers.
Although
many
standard
dermatotherapeutics
modulate
function,
therapy
rarely
targets
mitochondria.
Accordingly,
there
rationale
for
'mitochondrial
dermatology'-based
approaches
to
be
applied
therapeutic
research,
as
we
advocate
here.Areas
covered
This
paper
examines
cutaneous
physiology
beyond
energy
(ATP)
production.
Keratinocyte
differentiation
epidermal
barrier
maintenance,
appendage
morphogenesis
homeostasis,
photoaging
cancer
considered.
Based
on
related
PubMed
search
results,
evaluates
thyroid
hormones,
glucocorticoids,
Vitamin
D3
derivatives,
retinoids,
cannabinoid
receptor
agonists,
PPARγ
thyrotropin,
thyrotropin-releasing
hormone
instructive
lead
compounds.
Moreover,
protein
MPZL3
promising
new
drug
target
future
dermatology'
highlighted.Expert
opinion
Future
research
should
have
medicine
emphasis.
Focusing
selected
agents,
targets,
silico
design,
model
will
fertilize
mito-centric
approach.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
174, С. 116574 - 116574
Опубликована: Апрель 8, 2024
Gastrointestinal
(GI)
cancer
is
one
of
the
most
severe
types
cancer,
with
a
significant
impact
on
human
health
worldwide.
Due
to
urgent
demand
for
more
effective
therapeutic
strategies
against
GI
cancers,
novel
research
metal
ions
treating
cancers
has
attracted
increasing
attention.
Currently,
accumulating
relationship
between
and
therapy,
several
have
been
discovered
induce
cell
death.
In
particular,
three
modes
death,
including
ferroptosis,
cuproptosis,
calcicoptosis,
become
focal
points
in
field
cancer.
Meanwhile,
other
also
found
trigger
death
through
various
mechanisms.
Accordingly,
this
review
focuses
mechanisms
ion-induced
hoping
provide
theoretical
support
further
therapies.
Bioelectricity,
Год журнала:
2025,
Номер
7(1), С. 29 - 57
Опубликована: Март 1, 2025
In
recent
years,
there
has
been
a
growing
interest
in
lysosomal
ion
channels
and
transporters
due
to
their
critical
role
maintaining
function
involvement
variety
of
diseases,
particularly
storage
cancer,
neurodegenerative
disorders.
Recent
advancements
research
techniques,
including
manual
automated
patch
clamp
(APC)
electrophysiology,
solid-supported
membrane-based
electrophysiology
(SSME),
fluorescence-based
imaging,
have
further
enhanced
our
ability
investigate
both
physiological
pathological
conditions,
spurring
drug
discovery
efforts.
Several
pharmaceutical
companies
are
now
developing
therapies
aimed
at
modulating
these
improve
disease.
Small
molecules
targeting
like
transient
receptor
potential
mucolipin
(TRPML)
1
TMEM175,
as
well
drugs
pH,
currently
preclinical
clinical
development.
This
review
provides
an
overview
the
health
disease,
highlights
cutting-edge
techniques
used
study
them,
discusses
therapeutic
treatment
various
diseases.
Furthermore,
addition
summarizing
discoveries,
we
contribute
novel
functional
data
on
cystinosin,
TRPML1,
two-pore
channel
2
(TPC2),
utilizing
SSME
APC
approaches.
Pharmacological Research,
Год журнала:
2023,
Номер
189, С. 106703 - 106703
Опубликована: Фев. 17, 2023
Gastric
cancer
remains
one
of
the
most
common
deadly
diseases
and
lacks
effective
targeted
therapies.
In
present
study,
we
confirmed
that
signal
transducer
activator
transcription
3
(STAT3)
is
highly
expressed
associated
with
a
poor
prognosis
in
gastric
cancer.
We
further
identified
novel
natural
product
inhibitor
STAT3,
termed
XYA-2,
which
interacts
specifically
SH2
domain
STAT3
(Kd
=
3.29
μM)
inhibits
IL-6-induced
phosphorylation
at
Tyr705
nuclear
translocation.
XYA-2
inhibited
viability
seven
human
cell
lines
72-h
IC50
values
ranging
from
0.5
to
0.7
μΜ.
1
μΜ
colony
formation
migration
ability
MGC803
(72.6%
67.6%,
respectively)
MKN28
(78.5%
96.6%,
cells.
vivo
studies,
intraperitoneal
administration
(10
mg/kg/day,
7
days/week)
significantly
suppressed
59.8%
88.8%
tumor
growth
MKN28-derived
xenograft
mouse
model
MGC803-derived
orthotopic
model,
respectively.
Similar
results
were
obtained
patient-derived
(PDX)
model.
Moreover,
treatment
extended
survival
mice
bearing
PDX
tumors.
The
molecular
mechanism
studies
based
on
transcriptomics
proteomics
analyses
indicated
might
exert
its
anticancer
activity
by
synergistically
inhibiting
expression
MYC
SLC39A10,
two
downstream
genes
vitro
vivo.
Together,
these
findings
suggested
may
be
potent
for
treating
cancer,
dual
inhibition
SLC39A10
an
therapeutic
strategy
STAT3-activated
ACS Applied Materials & Interfaces,
Год журнала:
2024,
Номер
16(6), С. 6689 - 6708
Опубликована: Фев. 1, 2024
Tumor
development
and
metastasis
are
closely
related
to
the
complexity
of
metabolism
network.
Recently,
reprogramming
strategies
have
attracted
much
attention
in
tumor
therapy.
Although
there
is
preliminary
success
therapy
agents,
their
therapeutic
effects
been
restricted
by
effective
reaching
sites
drugs.
Nanodelivery
systems
with
unique
physical
properties
elaborate
designs
can
specifically
deliver
tumors.
In
this
review,
we
first
summarize
research
progress
nanodelivery
based
on
enhance
therapies
depleting
glucose,
inhibiting
glycolysis,
lactic
acid,
lipid
metabolism,
glutamine
glutathione,
disrupting
metal
metabolisms
combined
other
therapies,
including
chemotherapy,
radiotherapy,
photodynamic
therapy,
etc.
We
further
discuss
detail
advantages
for
As
well
as
opportunities
challenges
integrating
into
analyze
outlook
these
emerging
areas.
This
review
expected
improve
our
understanding
modulating
enhanced
Toxicological Sciences,
Год журнала:
2023,
Номер
192(2), С. 141 - 154
Опубликована: Фев. 8, 2023
Abstract
Cell
death
is
a
fundamental
biological
process,
and
its
fine-tuned
regulation
required
for
life.
However,
the
complexity
of
regulated
cell
often
reduced
to
matter
live-dead
discrimination.
Here,
we
provide
perspective
on
programmed
or
death,
focusing
apoptosis,
pyroptosis,
necroptosis,
ferroptosis
(the
latter
three
modalities
are
examples
necrosis).
We
also
touch
other,
recently
described
manifestations
(pathological)
including
cuproptosis.
Furthermore,
address
how
engineered
nanomaterials
impact
death.
posit
that
an
improved
understanding
nanomaterial-induced
perturbations
may
allow
better
prediction
consequences
human
exposure
these
materials
could
yield
novel
approaches
by
which
mitigate
their
effects.
Finally,
harnessing
achieve
cancer
killing
through
induction
Abstract
Ischemic
stroke
is
a
leading
cause
of
death
and
disability
worldwide,
presently,
there
no
effective
neuroprotective
therapy.
Zinc
an
essential
trace
element
that
plays
important
physiological
roles
in
the
central
nervous
system.
Free
zinc
concentration
tightly
regulated
by
zinc-related
proteins
brain
under
normal
conditions.
Disruption
homeostasis,
however,
has
been
found
to
play
role
mechanism
injury
following
ischemic
stroke.
A
large
free
releases
from
storage
sites
after
cerebral
ischemia,
which
affects
functions
survival
nerve
cells,
including
neurons,
astrocytes,
microglia,
resulting
cell
death.
Ischemia-triggered
intracellular
accumulation
also
disrupts
function
blood–brain
barrier
via
increasing
its
permeability,
impairing
endothelial
function,
altering
tight
junction
levels.
Oxidative
stress
neuroinflammation
have
reported
be
as
major
pathological
mechanisms
ischemia/reperfusion
injury.
Studies
showed
could
impair
mitochondrial
result
oxidative
stress,
form
positive
feedback
loop
between
reactive
oxygen
species
production,
leads
series
harmful
reactions.
Meanwhile,
elevated
neuroinflammation.
Recent
studies
autophagy
one
toxicity
Interrupting
will
reduce
ischemia
improve
neurological
outcomes.
This
review
summarizes
cellular
tissue
damage
focusing
on
about
inflammation,
autophagy.
Medicinal Research Reviews,
Год журнала:
2024,
Номер
44(6), С. 2472 - 2509
Опубликована: Май 6, 2024
Previously,
lysosomes
were
primarily
referred
to
as
the
digestive
organelles
and
recycling
centers
within
cells.
Recent
discoveries
have
expanded
lysosomal
functional
scope
revealed
their
critical
roles
in
nutrient
sensing,
epigenetic
regulation,
plasma
membrane
repair,
lipid
transport,
ion
homeostasis,
cellular
stress
response.
Lysosomal
dysfunction
is
also
found
be
associated
with
aging
several
diseases.
Therefore,
function
of
macroautophagy,
a
lysosome-dependent
intracellular
degradation
system,
has
been
identified
one
updated
twelve
hallmarks
aging.
In
this
review,
we
begin
by
introducing
concept
quality
control
(LQC),
which
machinery
that
maintains
number,
morphology,
through
different
processes
such
biogenesis,
reformation,
fission,
fusion,
turnover,
lysophagy,
exocytosis,
permeabilization
repair.
Next,
summarize
results
from
studies
reporting
association
between
LQC
dysregulation
aging/various
disorders.
Subsequently,
explore
emerging
therapeutic
strategies
target
distinct
aspects
for
treating
diseases
combatting
Lastly,
underscore
existing
knowledge
gap
propose
potential
avenues
future
research.
Cell Proliferation,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 1, 2024
Abstract
SLC7A11
plays
a
pivotal
role
in
tumour
development
by
facilitating
cystine
import
to
enhance
glutathione
synthesis
and
counteract
oxidative
stress.
Disulphidptosis,
an
emerging
form
of
cell
death
observed
cells
with
high
expression
under
glucose
deprivation,
is
regulated
through
reduction–oxidation
reactions
disulphide
bond
formation.
This
process
leads
contraction
collapse
the
F‐actin
cytoskeleton
from
plasma
membrane,
ultimately
resulting
cellular
demise.
Compared
other
forms
death,
disulphidptosis
exhibits
distinctive
characteristics
regulatory
mechanisms.
mechanism
provides
novel
insights
innovative
strategies
for
cancer
treatment
while
also
inspiring
potential
therapeutic
approaches
diseases.
Our
review
focuses
on
elucidating
molecular
underlying
its
connection
actin
cytoskeleton,
identifying
alternative
metabolic
as
well
offering
into
disulphidptosis‐based
therapy.
A
comprehensive
understanding
will
contribute
our
knowledge
about
fundamental
homeostasis
facilitate
groundbreaking
therapies
disease
treatment.
Journal of Pharmacology and Experimental Therapeutics,
Год журнала:
2024,
Номер
unknown, С. JPET - 002021
Опубликована: Янв. 31, 2024
Glioblastoma
(GBM)
is
the
most
frequently
diagnosed
primary
central
nervous
system
tumor
in
adults.
Despite
standard
of
care
therapy,
which
includes
surgical
resection,
temozolomide
chemotherapy,
radiation
and
newly
added
tumor-treating
fields,
median
survival
remains
only
∼20
months.
Unfortunately,
GBM
has
a
∼100%
recurrence
rate,
but
after
there
are
no
Food
Drug
Administration-approved
therapies
to
limit
growth
enhance
patient
survival,
as
these
tumors
resistant
(TMZ).
Recently,
our
laboratory
reported
that
lucanthone
slows
by
inhibiting
autophagic
flux
through
lysosome
targeting
decreases
number
Olig2+
glioma
stem-like
cells
(GSC)
vitro
vivo.
We
now
additionally
report
efficiently
abates
stemness
patient-derived
GSC
reduces
microtube
formation
GSC,
an
emerging
hallmark
treatment
resistance
GBM.
In
derived
from
with
acquired
TMZ,
retains
ability
perturb
growth,
inhibits
autophagy
lysosomes,
Olig2
positivity.
also
find
may
act
inhibitor
palmitoyl
protein
thioesterase
1.
Our
results
suggest
function
potential
option
for
not
amenable
TMZ
treatment.
SIGNIFICANCE
STATEMENT
antischistosome
agent
impedes
preclinical
model
temozolomide-resistant
glioblastoma
numbers
cells.
addition,
it
acts
inhibitor,
its
mechanism
action
be
via
inhibition
As
defined
approved
recurrent,
TMZ-resistant
tumor,
could
emerge
both
recurrent
settings.